AB
TXG icon

Amalgamated Bank’s 10x Genomics TXG Stock Holding History

Amalgamated Bank’s Portfolio TXG Stock Details TXG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-3,471
Closed -$57K – 2743
2025
Q4 		$57K Sell
3,471
-207
-6% -$3.13K ﹤0.01% 1799
2025
Q3 		$43K Hold
3,678
– – ﹤0.01% 1888
2025
Q2 		$43K Sell
3,678
-2,735
-43% -$24.9K ﹤0.01% 1862
2025
Q1 		$56K Buy
6,413
+561
+10% +$7.07K ﹤0.01% 1783
2024
Q4 		$84K Sell
5,852
-317
-5% -$5K ﹤0.01% 1739
2024
Q3 		$139K Hold
6,169
– – ﹤0.01% 1647
2024
Q2 		$120K Buy
6,169
+152
+3% +$3.98K ﹤0.01% 1683
2024
Q1 		$226K Sell
6,017
-12,632
-68% -$555K ﹤0.01% 1568
2023
Q4 		$1.04M Sell
18,649
-3,887
-17% -$169K 0.01% 1150
2023
Q3 		$930K Buy
22,536
+2,538
+13% +$132K 0.01% 1147
2023
Q2 		$1.12M Buy
19,998
+1,128
+6% +$61.1K 0.01% 1093
2023
Q1 		$1.05M Sell
18,870
-1,920
-9% -$89.7K 0.01% 1101
2022
Q4 		$758K Buy
20,790
+342
+2% +$11.2K 0.01% 1261
2022
Q3 		$582K Buy
20,448
+535
+3% +$20.4K 0.01% 1364
2022
Q2 		$901K Buy
19,913
+362
+2% +$18.8K 0.01% 1189
2022
Q1 		$1.49M Buy
19,551
+1,602
+9% +$140K 0.01% 1044
2021
Q4 		$2.67M Buy
17,949
+2,244
+14% +$344K 0.02% 805
2021
Q3 		$2.29M Sell
15,705
-923
-6% -$158K 0.02% 863
2021
Q2 		$3.26M Buy
16,628
+5,998
+56% +$1.09M 0.03% 750
2021
Q1 		$1.92M Sell
10,630
-985
-8% -$170K 0.07% 251
2020
Q4 		$1.65M Sell
11,615
-2
-0% -$290 0.06% 309
2020
Q3 		$1.45M Buy
11,617
+331
+3% +$34.7K 0.06% 308
2020
Q2 		$1.01M Buy
+11,286
New +$879K 0.05% 417

Other funds holding TXG

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
QCM
Quantinno Capital Management New York $59.9B AUM 28.07% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Amalgamated Bank's TXG Position: Q1 2026 in Review

Amalgamated Bank sold out of 10x Genomics (TXG) in Q1 2026, closing a stake of 3,471 shares — an estimated $57K sold.

Amalgamated Bank first reported a position in TXG in Q2 2020 and held it in 23 quarters. The position peaked at $3.26M in Q2 2021. 330 funds tracked by Wall St. Rank hold TXG as of Q1 2026.

  • Amalgamated Bank reported no remaining 10x Genomics position as of Q1 2026 after selling out during the quarter.
  • Amalgamated Bank sold 3,471 10x Genomics shares in Q1 2026, an estimated $57K.
  • Amalgamated Bank first reported a position in 10x Genomics in Q2 2020 and held it in 23 quarters.
  • Amalgamated Bank's 10x Genomics position peaked at $3.26M in Q2 2021.
  • 330 funds tracked by Wall St. Rank held 10x Genomics as of Q1 2026.

Based on Amalgamated Bank's 13F filing for Q1 2026, filed 8 May 2026.